Skip to content
Announcement:

Register and join online for the fireside chat: Creating a Powerful NAM respiratory Toxicology Strategy for Clinical Predictivity and IND Success on the 17th October 2024

Lung Platform Capabilities

Find out more about our lung airway models here

Read about our case study on Quantitative Fibroblast-to- Myofibroblast Transition (FMT) studies here 

Discover our blog on Overcoming optimisation hurdles of high-throughput FMT assay

Share on social media:

Don't miss out on our latest innovations: follow us on Linkedin

Get our latest updates straight to your inbox